Search results
Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial
Pharmaceutical Technology· 2 days agoAdditionally, the company says the therapy can overcome common resistance pathways associated with...
Too much data: a burden or a blessing?
Clinical Trials Arena· 2 days agoAs technology evolves and it becomes easier to collect data, the question is now if data collection has tipped too far. Extra data can be incredibly...
Biden Faces Mounting Speculation, Pressure To Drop Bid
NDTV Profit· 2 days agoSpeculation over if, when, or how Biden might step aside dominated the political conversation ahead...
COVID-19 is on the rise this summer. How concerned should you be?
Deseret News· 2 days agoThat recommendation holds even if a person has had a previous COVID-19 vaccine. Moderna, Novavax and...
Biden ‘Fine,’ Campaign Insists, as Pressure Mounts
Livemint· 2 days agoPresident Joe Biden is doing “fine” a day after testing positive for Covid-19, an adviser said Thursday. Increasingly public warnings from top Democratic lawmakers left his reelection effort ...
Exclusive-Collaboration software maker Smartsheet fields buyout interest, sources say
Theprint· 3 days agoSmartsheet’s software allows organizations to manage, track and automate their workflow using a...
CytoReason secures $80m investment for AI expansion
Pharmaceutical Technology· 3 days agoCytoReason has secured $80m in funding from a consortium of investors to enhance its AI disease models. The investors are OurCrowd, NVIDIA, Pfizer and...
Major NC companies relax mandatory retirement ages for board directors, CEOs
Durham Herald-Sun· 3 days agoAs age in politics sparks debate, S&P 500 companies are allowing board members to serve later into...
Alembic Pharmaceuticals Ltd Stock Price: Alembic Pharma Share Price Today | India Infoline
India Infoline· 3 days agoAlembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world. The companys state of the art research and manufacturing facilities are approved by regulatory ...
Joe Biden Is On Paxlovid, Drug Controversially Known For 'COVID Rebound'
Times Now· 3 days agoPresident Joe Biden tested positive for COVID-19 on Wednesday, the White House announced. The...
